“Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives As COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics by Molecular Docking and the Swiss ADME Studies”. Baghdad Science Journal, vol. 21, no. 4, Apr. 2024, p. 1255, https://doi.org/10.21123/bsj.2023.8295.